- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 303/14 - Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
Patent holdings for IPC class C07D 303/14
Total number of patents in this class: 85
10-year publication summary
5
|
5
|
7
|
4
|
4
|
4
|
7
|
3
|
1
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Del Mar Pharmaceuticals | 18 |
6 |
QBiotics Pty Ltd | 29 |
5 |
Del Mar Pharmaceuticals (BC) Ltd. | 17 |
4 |
China Petroleum & Chemical Corporation | 1911 |
3 |
Sumitomo Chemical Company, Limited | 9079 |
2 |
Kao Corporation | 4984 |
2 |
The Brigham and Women's Hospital, Inc. | 2215 |
2 |
Fundacion Tecnalia Research & Innovation | 221 |
2 |
JNC Corporation | 1568 |
2 |
JNC Petrochemical Corporation | 400 |
2 |
Profectus Biosciences, Inc. | 10 |
2 |
QBiotics Limited | 7 |
2 |
Research Institute of Petroleum Processing, Sinopec | 372 |
2 |
Washington University | 1625 |
2 |
Green Lizard Technologies Ltd | 13 |
2 |
BASF SE | 21017 |
1 |
Sandoz AG | 1416 |
1 |
Centre National de La Recherche Scientifique | 10564 |
1 |
Cheil Industries Inc. | 847 |
1 |
Corning Incorporated | 10320 |
1 |
Other owners | 40 |